Mitochondrial very long chain acyl-CoA dehydrogenase deficiency--a new disorder of fatty acid oxidation. 1995

C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
Hopital Huriez, Lille, France, Department of Paediatrics, France.

Very long chain acyl-CoA dehydrogenase is a newly characterised enzyme in mitochondrial fatty acid oxidation. A girl who presented on the second day of life with a sudden and severe illness due to deficiency of this enzyme is reported. There is evidence that some children (and perhaps all) originally diagnosed with a deficiency of long-chain acyl-CoA dehydrogenase, in fact, have a defect involving very long chain acyl-CoA dehydrogenase.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017240 Mitochondrial Myopathies A group of muscle diseases associated with abnormal mitochondria function. Myopathies, Mitochondrial,Luft Disease,Luft's Disease,Megaconial Myopathies,Mitochondrial Myopathy,Pleoconial Myopathies,Disease, Luft,Disease, Luft's,Lufts Disease,Megaconial Myopathy,Myopathies, Pleoconial,Myopathy, Megaconial,Myopathy, Pleoconial,Pleoconial Myopathy
D044942 Acyl-CoA Dehydrogenase, Long-Chain A flavoprotein oxidoreductase that has specificity for long-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE. Long-Chain-Acyl-CoA Dehydrogenase,Decanoyl CoA Dehydrogenase,Decanoyl CoA-Dehydrogenase,Long-Chain-Acyl-Coenzyme A Dehydrogenase,VLCAD,Very-Long-Chain Acyl-CoA Dehydrogenase,Acyl CoA Dehydrogenase, Long Chain,Acyl-CoA Dehydrogenase, Very-Long-Chain,CoA Dehydrogenase, Decanoyl,CoA-Dehydrogenase, Decanoyl,Dehydrogenase, Decanoyl CoA,Dehydrogenase, Long-Chain Acyl-CoA,Dehydrogenase, Long-Chain-Acyl-CoA,Dehydrogenase, Long-Chain-Acyl-Coenzyme A,Dehydrogenase, Very-Long-Chain Acyl-CoA,Long Chain Acyl CoA Dehydrogenase,Long Chain Acyl Coenzyme A Dehydrogenase,Long-Chain Acyl-CoA Dehydrogenase,Very Long Chain Acyl CoA Dehydrogenase
D018752 Diet, Fat-Restricted A diet that contains limited amounts of fat with less than 30% of calories from all fats and less than 10% from saturated fat. Such a diet is used in control of HYPERLIPIDEMIAS. (From Bondy et al, Metabolic Control and Disease, 8th ed, pp468-70; Dorland, 27th ed) Diet, Fat-Free,Diet, Low-Fat,Fat-Restricted Diet,Diet, Fat Free,Diet, Fat Restricted,Diet, Low Fat,Diets, Fat-Free,Diets, Fat-Restricted,Diets, Low-Fat,Fat Restricted Diet,Fat-Free Diet,Fat-Free Diets,Fat-Restricted Diets,Low-Fat Diet,Low-Fat Diets

Related Publications

C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
February 2019, Journal of human genetics,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
April 2002, Nihon rinsho. Japanese journal of clinical medicine,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
January 2001, Ryoikibetsu shokogun shirizu,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
January 2001, Ryoikibetsu shokogun shirizu,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
January 1998, Ryoikibetsu shokogun shirizu,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
October 1994, European journal of pediatrics,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
March 1993, Biochemical and biophysical research communications,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
January 1996, Journal of inherited metabolic disease,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
February 2014, Muscle & nerve,
C Largillière, and C Vianey-Saban, and M Fontaine, and C Bertrand, and N Kacet, and J P Farriaux
December 2009, Laboratory investigation; a journal of technical methods and pathology,
Copied contents to your clipboard!